Literature DB >> 27745633

Low-dose systemic corticosteroid treatment for recalcitrant hidradenitis suppurativa.

Dennis Wong1, Scott Walsh2, Raed Alhusayen2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27745633     DOI： 10.1016/j.jaad.2016.06.001

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  10 in total

Review 1.  The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.

Authors:  Ahmed Shah; Raed Alhusayen; Saeid Amini-Nik
Journal:  Inflamm Res       Date:  2017-06-27       Impact factor: 4.575

2.  A Case of Pemphigus Vulgaris and Hidradenitis Suppurativa: May Systemic Steroids Be Considered in the Standard Management of Hidradenitis Suppurativa?

Authors:  Fabrizio Martora; Lorenzo Martora; Gabriella Fabbrocini; Claudio Marasca
Journal:  Skin Appendage Disord       Date:  2022-01-26

Review 3.  Advances in molecular pathogenesis of hidradenitis suppurativa: Dysregulated keratins and ECM signaling.

Authors:  Mahendra Pratap Kashyap; Jasim Khan; Rajesh Sinha; Lin Jin; Venkatram Atigadda; Jessy S Deshane; Ayesha R Ahmed; Ali Kilic; Chander Raman; M Shahid Mukhtar; Craig A Elmets; Mohammad Athar
Journal:  Semin Cell Dev Biol       Date:  2022-02-04       Impact factor: 7.499

Review 4.  North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management.

Authors:  Ali Alikhan; Christopher Sayed; Afsaneh Alavi; Raed Alhusayen; Alain Brassard; Craig Burkhart; Karen Crowell; Daniel B Eisen; Alice B Gottlieb; Iltefat Hamzavi; Paul G Hazen; Tara Jaleel; Alexa B Kimball; Joslyn Kirby; Michelle A Lowes; Robert Micheletti; Angela Miller; Haley B Naik; Dennis Orgill; Yves Poulin
Journal:  J Am Acad Dermatol       Date:  2019-03-11       Impact factor: 15.487

5.  Clinical and Ultrasonographic Profile of Adalimumab-treated Hidradenitis Suppurativa Patients: A Real-life Monocentric Experience.

Authors:  Andrea Chiricozzi; Giulia Giovanardi; Simone Garcovich; Dalma Malvaso; Giacomo Caldarola; Barbara Fossati; Cristina Guerriero; Clara De Simone; Ketty Peris
Journal:  Acta Derm Venereol       Date:  2020-06-11       Impact factor: 3.875

Review 6.  Review of Current Immunologic Therapies for Hidradenitis Suppurativa.

Authors:  Victoria K Shanmugam; Nadia Meher Zaman; Sean McNish; Faye N Hant
Journal:  Int J Rheumatol       Date:  2017-08-20

Review 7.  Topical, systemic and biologic therapies in hidradenitis suppurativa: pathogenic insights by examining therapeutic mechanisms.

Authors:  John W Frew; Jason E Hawkes; James G Krueger
Journal:  Ther Adv Chronic Dis       Date:  2019-03-01       Impact factor: 5.091

8.  The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study.

Authors:  A R J V Vossen; C B Ardon; H H van der Zee; E Lubberts; E P Prens
Journal:  Br J Dermatol       Date:  2019-04-12       Impact factor: 9.302

Review 9.  Efficacy and Toxicity of Classical Immunosuppressants, Retinoids and Biologics in Hidradenitis Suppurativa.

Authors:  Kinnor Das; Steven Daveluy; George Kroumpouzos; Komal Agarwal; Indrashis Podder; Katherine Farnbach; Alex G Ortega-Loayza; Jacek C Szepietowski; Stephan Grabbe; Mohamad Goldust
Journal:  J Clin Med       Date:  2022-01-27       Impact factor: 4.241

10.  Intermittent low-dose corticosteroid therapy for hidradenitis suppurativa: A case series.

Authors:  Andrés M Erlendsson; Louise Lönndahl; Hassan Killasli
Journal:  JAAD Case Rep       Date:  2021-05-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.